Genetic and epigenetic alterations as hallmarks of the intricate road to cancer
- 29 September 2003
- journal article
- review article
- Published by Springer Nature in Oncogene
- Vol. 22 (42) , 6472-6478
- https://doi.org/10.1038/sj.onc.1206955
Abstract
Despite the clonal origin of most tumors, their tremendous heterogeneity suggests that cancer progression springs from the combined forces of both genetic and epigenetic events, which produce variant clonal populations, together with the selective pressures of the microenvironment, which promote growth and, perhaps, dissemination of variants with a specific set of characteristics. Although the importance of genetic mutations in cancer has long been recognized, the role of epigenetic events has been suggested more recently. This review focuses on the genetic and epigenetic molecular mechanisms involved in cancer onset and progression, and discusses the possibility of new strategies in the development of anticancer treatments.Keywords
This publication has 78 references indexed in Scilit:
- Triggering of p73-dependent apoptosis in osteosarcoma is under the control of E2Fs–pRb2/p130 complexesOncogene, 2003
- Abolition of Cyclin-Dependent Kinase Inhibitor p16Ink4a and p21Cip1/Waf1 Functions Permits Ras-Induced Anchorage-Independent Growth in Telomerase-Immortalized Human FibroblastsMolecular and Cellular Biology, 2003
- Aberrant DNA Methylation in Lung Cancer: Biological and Clinical ImplicationsThe Oncologist, 2002
- Metastasis genes: A progression puzzleNature, 2002
- Ras family genes: An interesting link between cell cycle and cancerJournal of Cellular Physiology, 2002
- p53 gene mutation and ink4a-arf deletion appear to be two mutually exclusive events in human glioblastomaOncogene, 2000
- The language of covalent histone modificationsNature, 2000
- The Hallmarks of CancerCell, 2000
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- KAI1 , a Metastasis Suppressor Gene for Prostate Cancer on Human Chromosome 11p11.2Science, 1995